Germany is the main European ODA donor. According to the DAC, ODA represented 0,7% of its gross national income in 2016 (€ 22 billion in volume)1.

According to our methodology, Germany allocated €1.012 billion to global health in 2016.

Those substantial amounts in volume only represented 0.03% of its GNI, which means that Germany is far from complying with the recommendation of the WHO Commission on Macroeconomics and Health.


Germany’s DAH is almost equally split between bilateral (45%) and multilateral funding (55%) with a slightly stronger emphasis on the multilateral [2016].

The main recipients are global health initiatives such as the Global Fund to Fight AIDS, TB and Malaria and Gavi, the Vaccine Alliance.

Germany is also a large core contributor to the UN agencies such as the World Health Organisation and the UN Population Fund (UNFPA) and to development banks (concessional entities of the World Bank and the African Development Bank).

To Whom?

On average, Sri Lanka and Uzbekistan were the main recipients for German DAH in loans in 2014-2016 while Sierra Leone and Liberia were the first recipient countries of bilateral DAH grants.

Germany allocated a relatively large share of its DAH loans to upper-middle-income countries during the period of 2014-2016, which received 77% (average 2014-2016) of health ODA loans.
During the same period, upper-middle-income countries received an average share of 6% of DAH grants while low-income and lower-middle income countries respectively received an average share of 33% and 32%.

What for?

Our methodology is proposing an alternative classification to the CRS purpose codes. We’ve tried to classify the health projects according to the SDGs as an attempt to suggest different codes than those proposed by the Working Party on Development Finance Statistics and to produce more detailed information. As mentioned in the methodology, this report is made for food for thought and to trigger the discussions on improving the accuracy of ODA for health.

The fight against epidemics is the main sector financed by Germany, bilateral and multilateral channels aggregated.

In terms of loans only, support to health systems is emerging as the main funding pot: it represents around 60%. Equity are likewise exclusively invested in the support and reform of health systems.

It’s worth noting that family planning and reproductive care represent a relatively important share of bilateral DAH compared to other donors (21%). On the other hand, non-communicable diseases and neglected tropical diseases are under-funded (less than 0,5 million each per year in average) which is a common trend among the analysed donors.


In this project, we tried to assess to what extent each donor is contributing to Universal Health Coverage (UHC) taking into account the difficulty to formulate an extensive procedure to determine what is UHC and what is not. So far, we could only claim 8% of the projects of Germany for 2016 are contributing to UHC as a principle objective, mainly due to a lack of detailed information provided through the CRS.